Table 1 Characteristics of included studies
Author | Year | Study design | Gender male % | Age | Sample size | Follow-up (y) | Country | Patient | The NOS for assessing the quality of studies | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
Selection | Comparability | Exposure | |||||||||
Abualsuod [21] | 2015 | Retrospective cohort | 52% | 60.42 (13.36) | 720 | 1 | USA | MI + T2DM | ☆☆☆ | ☆ | ☆☆☆ |
Al Ali [22] | 2016 | RCT | 81% | 57.9 (11.4) | 237 | 0.3 | Netherlands | MI-T2DM | ☆☆☆☆ | ☆☆ | ☆☆ |
Basnet [23] | 2015 | Case control | 65% | – | 274 | 0.0 | USA | MI + T2DM | ☆☆☆ | ☆ | ☆☆ |
Chen [24] | 2016 | Retrospective cohort | 53% | 52.53 (10.07) | 179,742 | 0.3 | Canada | T2DM | ☆☆☆ | ☆ | ☆☆ |
Duncan [25] | 2007 | Retrospective cohort | 76% | 65 (58–72) | 1284 | 0.0 | USA | CVD + T2DM | ☆☆☆☆ | ☆ | ☆☆ |
Eppinga [26] | 2016 | RCT | 75% | 58.80 (11.82) | 371 | 0.3 | Netherlands | MI-T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Evans [27] | 2006 | Retrospective cohort | 51% | 60.2 | 7967 | 5.0 | UK | T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Facila [28] | 2017 | RCT | 56% | 71 (10) | 835 | 2.4 | Spain | HF + T2DM | ☆☆☆ | ☆☆ | ☆☆☆ |
Fung [29] | 2015 | Retrospective cohort | 40% | 61.70 (10.75) | 11,293 | 5.0 | China | T2DM | ☆☆☆☆ | ☆ | ☆☆☆ |
Hartman [30] | 2017 | RCT | – | – | 379 | 2.0 | Netherlands | MI-T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Hong [31] | 2013 | RCT | 78% | 62.8 (8.5) | 304 | 5.0 | China | CVD + T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Johnson [32] | 2005 | Retrospective cohort | 52% | 64.3 (12.4) | 4142 | 9.0 | Canada | T2DM | ☆☆☆ | ☆ | ☆☆☆ |
Jong [16] | 2019 | Retrospective cohort | 74% | 65.9 (10.8) | 636 | 2.0 | Taiwan | MI + T2DM | ☆☆☆ | ☆ | ☆☆ |
Kitao [33] | 2017 | RCT | 65% | 60 (20–74) | 96 | 0.3 | Japan | T2DM-CVD | ☆☆☆☆ | ☆☆ | ☆☆ |
Kooy [34] | 2009 | RCT | 41% | 64 (10) | 390 | 4.0 | Netherlands | T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Kruszelnicka [35] | 2015 | Case control | 60% | 67 (8) | 70 | 0.0 | Poland | CVD + T2DM | ☆☆☆ | ☆ | ☆☆ |
Lexis [36] | 2012 | RCT | – | – | 350 | 0.8–10.7 | Netherlands | MI-T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Lexis [37] | 2014 | Retrospective cohort | 64% | 66 (12) | 3948 | 0.3 | Netherlands | MI + T2DM | ☆☆☆ | ☆ | ☆ |
Lexis [38] | 2015 | RCT | 77% | 58.1 (11.9) | 346 | 0.4 | Netherlands | MI-T2DM | ☆☆☆☆ | ☆☆ | ☆☆ |
Lexis [39] | 2014a | RCT | 75% | 58.7 (11.8) | 379 | 0.3 | Netherlands | MI-T2DM | ☆☆☆☆ | ☆☆ | ☆☆ |
Li [40] | 2014 | RCT | 68% | 62.4 (11.0) | 152 | 1.0 | China | T2DM | ☆☆☆☆ | ☆ | ☆☆ |
Liu [41] | 2016 | Retrospective cohort | 44% | 60.7 | 272,149 | 7.4 | USA | T2DM | ☆☆ | ☆ | ☆ |
Liu [42] | 2017 | RCT | 47% | 59 (17) | 60 | 0.5 | China | CVD + T2DM | ☆☆☆ | ☆ | ☆ |
Morgan [43] | 2014 | Retrospective cohort | 36% | 66.6 (10.4) | 5208 | 0.0 | UK | T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Pantalone [44] | 2009 | Retrospective cohort | 42% | 56.8 (13.9) | 20,450 | n | USA | T2DM-CVD | ☆☆☆ | ☆ | ☆☆☆ |
Preiss [45] | 2014 | RCT | 81% | 63 (8) | 173 | 1.5 | UK | CVD-T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Rachmani [46] | 2002 | RCT | 53% | 65 (4) | 393 | 4.0 | Israel | T2DM | ☆☆ | ☆☆ | ☆☆ |
Raee [47] | 2017 | Retrospective cohort | 42% | 55 (11.1) | 717 | 13.6 | Iran | T2DM | ☆☆☆☆ | ☆ | ☆☆ |
Retwiński [48] | 2018 | Retrospective cohort | 70% | 64.5 (10.5) | 1030 | 1.0 | Poland | HF + T2DM | ☆☆☆☆ | ☆ | ☆☆☆ |
Romero [49] | 2013 | Retrospective cohort | 47% | 70.5 (7.0) | 1184 | 9.0 | Spain | HF + T2DM | ☆☆☆☆ | ☆ | ☆☆☆ |
Roumie [50] | 2012 | Retrospective cohort | 97% | 65 (57–74) | 161,296 | 5.0 | USA | T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Roumie [51] | 2017 | Retrospective cohort | 97% | 66 (57–75) | 131,972 | 7.5 | USA | T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Roussel [52] | 2010 | Retrospective cohort | 66% | 67.1 (9.3) | 19,691 | 2.0 | France | T2DM | ☆☆☆☆ | ☆ | ☆☆☆ |
Scheller [53] | 2014 | Retrospective cohort | 52% | 59.0 (15.2) | 84,756 | 4.0 | Denmark | T2DM | ☆☆☆☆ | ☆☆ | ☆☆☆ |
Schramm [54] | 2011 | Retrospective cohort | 51% | 52.5 (14.0) | 110,374 | 9.0 | Denmark | T2DM | ☆☆☆☆ | ☆ | ☆☆☆ |
Shah [55] | 2010 | Retrospective cohort | 79% | 56 (11) | 131 | 2.0 | USA | HF + T2DM | ☆☆☆ | ☆ | ☆☆☆ |
Sillars [56] | 2010 | Retrospective cohort | 44% | 60.6 (11.9) | 1271 | 15.0 | Australia | T2DM | ☆☆☆ | ☆ | ☆☆☆ |
Wang [57] | 2017 | Retrospective cohort | – | 72.49 (5.15) | 41,204 | 8.0 | USA | T2DM | ☆☆☆ | ☆ | ☆☆☆ |
Wong [58] | 2012 | RCT | 90% | 64 (8) | 62 | 0.3 | UK | HF-T2DM | ☆☆☆ | ☆☆ | ☆☆☆ |
Zeller [59] | 2016 | Case control | 76% | 61 (11) | 372 | 0.0 | France | MI + T2DM | ☆☆☆ | ☆ | ☆☆ |
Total studies | 40 | 1,066,408 | |||||||||